This inventor holds 1 USPTO granted patent. Top assignee: Bexel Pharmaceuticals, Inc.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Sangamesh Badiger: Innovator in Pharmaceutical Chemistry
Introduction
Sangamesh Badiger is a notable inventor based in Tamil Nadu, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that have potential therapeutic applications.
Latest Patents
Sangamesh holds a patent for diphenyl ether derivatives. These novel compounds exhibit activity that is useful for reducing glucose, cholesterol, and triglyceride levels in plasma. Additionally, they are aimed at treating obesity, inflammation, immunological diseases, autoimmune diseases, diabetes, and disorders associated with insulin resistance. His innovative work in this area has the potential to impact many lives positively.
Career Highlights
Sangamesh is currently associated with Bexel Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving health outcomes through innovative pharmaceutical solutions.
Collaborations
Some of his notable coworkers include Bishwajit Nag and Abhijeet Nag. Their collaborative efforts contribute to the dynamic research environment at Bexel Pharmaceuticals, Inc.
Conclusion
Sangamesh Badiger's contributions to pharmaceutical chemistry, particularly through his patent on diphenyl ether derivatives, highlight his role as an innovator in the field. His work promises to bring about significant advancements in the treatment of various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile